Business & Finance
Curatis secures Swiss distribution deal with Phoenix Labs
5 September 2025 - Swiss pharmaceutical company Curatis Holding AG (SIX:CURN) announced on Friday that it has signed a distribution agreement with healthcare company Phoenix Labs (Ireland) covering fo...
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
28 August 2025 - Pharmaceutical technology company Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) on Wednesday announced its financial consolidated results for the six months ended 30 ...
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
27 August 2025 - Wolters Kluwer Health (EURONEXT: WKL) announced on Wednesday that it has launched AI Article Summary on its Ovid platform, enabling researchers to quickly extract insights from peer-r...
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
26 August 2025 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Tuesday that the European Commission has granted marketing authorization for Yeytuo (lenacapavir), a twice-yea...
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
26 August 2025 - Canada-based pharmaceutical company ESSA Pharma Inc (NASDAQ:EPIX) on Monday issued a statement clarifying the period of due bill trading in connection with its USD80m return of capita...
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
21 August 2025 - Biotechnology company Alvotech SA (NASDAQ:ALVO) and pharmaceutical company Advanz Pharma Holdco Limited announced on Thursday that the European Commission has approved Mynzepli (AVT06...